HOSEIN CLYDE 4

What Happened

• Director Hosein Clyde reported an open-market purchase of 6,500 shares of DENTSPLY SIRONA (XRAY) on 2026-06-15 at $9.98 per share, for a total of $64,902. This was a purchase (insider acquisition), which investors often view as more informative than routine sales.

Key Details

• Transaction date: 2026-06-15
• Transaction type/code: Open-market purchase (P)
• Price per share: $9.98
• Shares acquired: 6,500
• Total value: $64,902
• Shares owned after the transaction: Not specified in the filing
• Footnotes/plan: Filing does not indicate a 10b5-1 plan, tax withholding, or other special conditions
• Filing timeliness: Report filed 2026-06-16 (next day), appears timely

Context

• The purchase is relatively small in dollar terms (~$65k) and may not be material to the company. Open-market buys can signal insider confidence but can also reflect personal portfolio decisions; the filing provides no explanation. For investors, note the purchase, but consider it alongside other insider activity and company fundamentals.